• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Latrunculin B

Latrunculin B

Product ID L0077
Cas No. 76343-94-7
Purity
Product Unit SizeCostQuantityStock
1 mg $251.50 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Latrunculin B is a thiazolidinone macrolide found in the Red Sea sponge. Latrunculin acts as an actin inhibitor, binding to G-actin and preventing its transition to F-actin and actin polymerization. This action results in inhibition of rhizoid formation in plants and alterations in Ca2+ trafficking in macrophages. Latrunculin B also exhibits anticancer activity; it induces breaks in double-stranded DNA and increases levels of Bax to induce apoptosis in vitro. Additionally, this compound induces actin microfilament destabilization in prostate cancer cells.

Product Info

Cas No.

76343-94-7

Formula

C20H29NO5S

Formula Wt.

395.51

IUPAC Name

(4S)-4-[(4Z,8Z,13R,15R)-15-Hydroxy-5,10-dimethyl-3-oxo-2,14-dioxabicyclo[11.3.1]heptadeca-4,8-dien-15-yl]-1,3-thiazolidin-2-one

Solubility

Ethanol

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

L0077 MSDS PDF

Info Sheet

L0077 Info Sheet PDF

References

Ahn YT, Shin IJ, Kim JM, et al. Counteracting the activation of pAkt by inhibition of MEK/Erk inhibition reduces actin disruption-mediated apoptosis in PTEN-null PC3M prostate cancer cell lines. Oncol Lett. 2013 Nov;6(5):1383-1389. PMID: 24179529.

Helal MA, Khalifa S, Ahmed S. Differential binding of latrunculins to G-actin: a molecular dynamics study. J Chem Inf Model. 2013 Sep 23;53(9):2369-75. PMID: 23988111.

Kudrimoti S, Ahmed SA, Daga PR, et al. Semisynthetic latrunculin B analogs: studies of actin docking support a proposed mechanism for latrunculin bioactivity. Bioorg Med Chem. 2009 Nov 1;17(21):7517-22. PMID: 19800245.

Yoshida K, Shimmen T. Involvement of actin filaments in rhizoid morphogenesis of Spirogyra. Physiol Plant. 2009 Jan;135(1):98-107. PMID: 19121103.

Kurilova LS, Krutetskaia ZI, Lebedev OE. Effect of latrunculin B, jasplakinolide and brefeldin A on the store-dependent Ca2+ entry in macrophages. Tsitologiia. 2006;48(10):867-74. PMID: 17162846.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • A0534

    Abiraterone

    Progesterone derivative; Cyp17A1 inhibitor.
    ≥99%
  • C1609

    Cecropin B

    Antimicrobial peptide found in Hyalophora cecropia...
    ≥95%
  • T6933

    Trichostatin A

    HDAC inhibitor, mammalian RNA splicing modulator.
    ≥98%
  • N5409

    Nocodazole

    Microtubule polymerization inhibitor.
    ≥98%
  • I4000

    Ikarugamycin

    Protein translation inhibitor.
    ≥98%
  • V3444

    Vilazodone

    5-HT1A partial agonist, SERT inhibitor.
    ≥98%
  • A5161

    Ampiroxicam

    Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
    ≥98%
  • A4679

    Altrenogest

    Synthetic progestogen; PR agonist.
    ≥98%
  • K0022

    K252b

    Staurosporine analog; PKC inhibitor.
    ≥98%
  • T5720

    Tofacitinib Citrate

    JAK1/2/3 inhibitor.
    ≥99%
  • AS102

    Aristolochic Acids Standards Kit

    Aristolochic Acids Standards Kit Contents: -Column...
  • Z3444

    Zileuton

    5-Lipoxygenase inhibitor.
    ≥98%
  • S0225

    SAG Dihydrochloride

    Smoothened agonist.
    ≥98%
  • D5747

    Dolasetron Mesylate Hydrate

    5-HT3 antagonist.
    ≥98%
  • A6828

    N(α),N(α)-Dimethyl-L-Arginine Ammonium

    Endogenous amino acid derivative, regulates water/...
    ≥98%
  • O4400

    Olanzapine

    AMPK activator, D1-4, 5-HT1A/2/3/6/7, M1-5 mAChR, ...
    ≥98%
  • G4479

    Glucagon (19-29), human

    Endogenous peptide hormone, glugagon fragment; pot...
    ≥95%
  • V3212

    Vidarabine

    Nucleoside (adenosine) analog; viral DNA polymeras...
    ≥98%
  • F1745

    Felodipine

    Dihydropyridine; L-type Ca2+ channel blocker.
    ≥98%
  • A0001

    A-803467

    Nav1.8 Na+ channel blocker, potential Nav1.5 Na+ c...
    ≥97%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only